Carregant...
Unique Metabolomic Signature Associated with Hepatorenal Dysfunction and Mortality in Cirrhosis
The application of non-targeted metabolomic profiling has recently become a powerful non-invasive tool to discover new clinical biomarkers. This study aimed to identify metabolic pathways that could be exploited for prognostic and therapeutic purposes in hepatorenal dysfunction in cirrhosis. One hun...
Guardat en:
| Publicat a: | Transl Res |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037419/ https://ncbi.nlm.nih.gov/pubmed/29291380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2017.12.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|